Improving the accuracy of revised cardiac risk index with HbA1C: Hemoglobin ratio (HH ratio) - A retrospective cohort study
- PMID: 37035307
- PMCID: PMC10079950
- DOI: 10.3389/fmed.2023.998477
Improving the accuracy of revised cardiac risk index with HbA1C: Hemoglobin ratio (HH ratio) - A retrospective cohort study
Abstract
Background: The current Lee's Revised cardiac risk index (RCRI) was created in 1999. Validation studies have found RCRI to be only moderately discriminant. The "Diabetes Mellitus on insulin" component of the score does not accurately reflect the severity of the disease. A previously studied HbA1C:Hemoglobin ratio shows an improved association with outcomes than individual components alone.
Study design: A retrospective cohort study was performed in diabetic patients undergoing non-cardiac surgery. Ethics approval was obtained. The study compares the predictive value of RCRI and substitution of the "DM on insulin" component with HH ratio for 30- and 90-day mortality, and postoperative acute myocardial injury (AMI) and acute kidney injury (AKI).
Results: A total of 20,099 adult patients were included in the final analysis. The incidence of 30- and 90-day mortality was at 4.2 and 6.5%, respectively. Substitution of HH ratio in RCRI resulted in 687 more patients being in the moderate to high-risk category. The substituted HH-RCRI score had better prediction for 30-day (AUC 0.66 vs. 0.69, p < 0.001) and 90-day mortality (AUC 0.67 vs. 0.70, p < 0.001), and postoperative AMI (AUC 0.69 vs. 0.71, p < 0.001) and AKI (AUC 0.57 vs. 0.62, p < 0.001).
Conclusion: Although currently not an universal practice, substitution of "DM on insulin" with HbA1C:Hemoglobin ratio in RCRI score improves the accuracy of the RCRI risk prediction model in diabetic patients going for non-cardiac surgery.
Keywords: HH ratio; HbA1c (glycated hemoglobin test); diabetes mellitus; revised cardiac risk index (RCRI); risk model.
Copyright © 2023 Ke, Shannon and Abdullah.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Application of the Revised Cardiac Risk Index to the Model for End-Stage Liver Disease Score Improves the Prediction of Cardiac Events in Patients Undergoing Liver Transplantation.Transplant Proc. 2018 May;50(4):1108-1113. doi: 10.1016/j.transproceed.2018.01.024. Transplant Proc. 2018. PMID: 29731076
-
The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients.J Vasc Surg. 2010 Sep;52(3):674-83, 683.e1-683.e3. doi: 10.1016/j.jvs.2010.03.031. Epub 2010 Jun 8. J Vasc Surg. 2010. PMID: 20570467
-
Combining CHA2DS2-VASc score into RCRI for prediction perioperative cardiovascular outcomes in patients undergoing non-cardiac surgery: a retrospective pilot study.BMC Anesthesiol. 2021 Nov 9;21(1):276. doi: 10.1186/s12871-021-01496-2. BMC Anesthesiol. 2021. PMID: 34753422 Free PMC article.
-
Limited Predictive Role of the Revised Cardiac Risk Index in Kidney Transplant: Single Center Evaluation and Comparison With International Literature.Curr Probl Cardiol. 2021 Sep;46(9):100908. doi: 10.1016/j.cpcardiol.2021.100908. Epub 2021 May 30. Curr Probl Cardiol. 2021. PMID: 34217501 Review.
-
Proposed research plan for the derivation of a new Cardiac Risk Index.Anesth Analg. 2015 Mar;120(3):543-553. doi: 10.1213/ANE.0000000000000598. Anesth Analg. 2015. PMID: 25695572 Review.
References
LinkOut - more resources
Full Text Sources